Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 460.00
Bid: 450.00
Ask: 470.00
Change: -30.00 (-6.12%)
Spread: 20.00 (4.444%)
Open: 490.00
High: 490.00
Low: 455.00
Prev. Close: 460.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Apr 2020 07:00

RNS Number : 8803K
System1 Group PLC
27 April 2020
 

 

 

Press Release

27 April 2020

 

 

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

 

UPDATE ON 2019/20 FINANCIAL YEAR; SYSTEM 1 RESPONSE TO COVID-19 IMPACT

 

System1 Group, the international online market research agency, is today providing the following Trading Update for its financial year to the end of March 2020, together with updates on the impact so far of the Covid-19 pandemic and related matters.

 

 

12 MONTHS TO END-MARCH 2020

 

In our Trading Update released on February 6, 2020, we reported that trading in Q4 to date had slowed. This remained the case through the final weeks of Q4. We therefore expect Sales Revenue and Gross Profit for Q4 to be approximately 25 % below that of the prior year and for the financial year as a whole to be down by approximately 2%, much as we anticipated in February.

 

The modestly reduced sales for the full year, together with a 1% increase in overhead expenditure, is expected to result in a 2019/20 Profit Before Tax figure (excluding AdRatings and share-based payments) of approximately £2.9m, compared with £3.6m in the prior year. Whilst we acknowledge this was a disappointing result, it does exceed our previous expectations.

 

Investment in AdRatings continued during the year, with expenditure of £1.8m recognised in the income statement, compared with £2.2m in 2018/19. In addition, an impairment charge of £0.9m has been taken in relation to AdRatings development costs in light of the continuing modest AdRatings revenues in the year (£0.05m). On the strength of the industry attention received by AdRatings, we have announced a strategic commercial partnership with ITV, the UK's largest seller of advertising space, to support its customers in creating ever more innovative and effective advertising. We expect to enjoy revenues from these arrangements although it is hard to quantify this while the Covid-19 pandemic continues.

 

 

SYSTEM1 RESPONSE TO COVID-19 IMPACT

 

In response to the Covid-19 pandemic, governments across the world have taken unprecedented actions in recent weeks to limit the spread of the virus. These actions vary considerably by country, and their impact varies considerably by business sector. Since the end of the 2019/20 financial year, System1's trading has inevitably been adversely affected by the global economic situation. The Board has concluded that it is difficult at this stage to provide guidance on the financial performance for the current year until a clearer outlook emerges. The Board will keep investors updated as the impact on the Group's performance becomes clearer.

 

System1's priority, as we face up to the challenge presented by the pandemic, is to maintain a strong financial position while safeguarding the human and intellectual capital needed to take advantage of the what the Board believes will be substantial growth opportunities when the global economy recovers. In accordance with this priority, we are monitoring the trends in forward sales, evaluating a variety of plausible revenue scenarios, and taking decisions on our cost base when agreed trigger points are reached. Mitigating actions to date include deferring employment costs, reducing the number of hours paid for where the volume of work has fallen, and taking advantage of government-backed business support and furloughing schemes in the countries where we operate. The Board and other senior executives of System1 have agreed to defer 20% of their salaries until further notice.

 

Given the emphasis on retaining cash in the current circumstances, the Board has decided to suspend both the proposed buyback programme of up to £1.5m of System1 shares as well as the payment of a final dividend for the 2019/20 financial year. Future returns of capital will be kept under review as the economic situation develops. In addition, the Company arranged and drew down a £2.5m revolving credit facility in March 2020, ending the year with a gross cash balance of £6.6m (2019: £4.3m) and debt of £2.5m.

 

At this difficult time we are working as closely as possible with our clients, sharing the latest insights on how Covid-19 has impacted consumer feelings and behaviour around the world and strengthening our relationships with them. We believe this will stand us in good stead and benefit our business when conditions improve.

 

The Company can be found at www.system1group.com.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

For further information, please contact:

 

System1 Group PLC

 

Tel: +44 (0)20 7043 1000

 

John Kearon, Chief Executive Officer

 

Chris Willford, Chief Financial Officer

 

 

Canaccord Genuity Limited

 

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUNOVRRSUSUAR
Date   Source Headline
16th Apr 20247:00 amRNSTrading Update
24th Jan 20247:00 amRNSTrading Update
12th Dec 202312:51 pmRNSPresentation via Investor Meet Company
6th Dec 20237:00 amRNSChange of Auditor
6th Dec 20237:00 amRNSInterim Results
24th Oct 20237:00 amRNSTrading Update
27th Sep 20236:00 pmRNSResult of AGM
27th Sep 20237:00 amRNSTrading Update
31st Aug 20237:00 amRNSAnnual Report and Notice of AGM
1st Aug 20237:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2023
31st Jul 20232:00 pmRNSPreliminary Results Presentation
13th Jul 20237:30 amRNSTrading update
30th Jun 20239:00 amRNSResolution of Complaint for Trademark Infringement
28th Jun 202311:00 amRNSHolding(s) in Company
3rd May 20233:15 pmRNSFurther re Result of General Meeting
21st Apr 202311:56 amRNSResult of General Meeting
13th Apr 20237:00 amRNSFurther re Requisitioned General Meeting
12th Apr 20237:00 amRNSTrading Update
5th Apr 202310:45 amRNSNotice of Trading Update
24th Mar 20234:00 pmRNSPosting of Circular and Notice of Requisitioned GM
24th Mar 20237:00 amRNSPosting of Circular and Notice of Requisitioned GM
7th Mar 20237:30 amRNSReceipt of Requisition Notice
28th Feb 202312:50 pmRNSCapital Markets Day
23rd Feb 20237:00 amRNSTrading Update
14th Feb 20237:00 amRNSCapital Markets Day
13th Jan 20232:00 pmRNSDirector/PDMR Shareholding
10th Jan 202310:30 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 20224:00 pmRNSDirector/PDMR Shareholding
13th Dec 20226:25 pmRNSDirector/PDMR Shareholding
6th Dec 20224:15 pmRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Results
25th Oct 20227:00 amRNSTrading Update
28th Sep 20226:15 pmRNSResult of AGM
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
12th Jul 20227:00 amRNSQuarterly Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.